At Qbtech we always strive to evaluate our tests in the clinical setting. Through independent collaborations with world leading researchers in the field, more than 30 studies have been performed with QbTest or QbCheck to address their validity, clinical utility and usefulness in treatment follow up. A comprehensive summary of our Clinical documentation can be found here.
Below please find abstracts for some key publications addressing different aspects of the tests:
The impact of a computerised test of attention and activity (QbTest) on diagnostic decision-making in children and young people with suspected attention deficit hyperactivity disorder: Single-blind randomised controlled trial.
Study of user experience of an objective test (QbTest) to aid ADHD assessment and medication management: A multi-methods approach.
Transforming ADHD Care Across the East Midlands - QbTest.
Innovations in Practice: an objective measure of attention, impulsivity and activity reduces time to confirm attention-deficit/hyperactivity disorder diagnosis in children – a completed audit cycle.
Assessments for attention-deficit hyperactivity disorder: Use of objective measurements.
Preliminary evidence for altered motion tracking based hyperactivity in ADHD siblings.
Attention-deficit hyperactivity disorder (ADHD) and glial integrity: An exploration of associations of cytokines and kynurenine metabolites with symptoms and attention.
Objective measurement of motor activity during cognitive performance in adults with attention-deficit/ hyperactivity disorder.
Measuring adult Attention Deficit Hyperactivity Disorder using the Quantified Behavior Test Plus.
The incremental validity of a computerised assessment added to clinical rating scales to differentiate adult ADHD from autism spectrum disorder
Assessing ADHD symptoms in children and adults: evaluating the role of objective measures.
Does atomoxetine improve executive function, inhibitory control, and hyperactivity? Results from a placebo-controlled trial using quantitative measurement technology.
Modulation of attention-deficit/hyperactivity disorder symptoms by short- and long-acting methylphenidate over the course of a day.
Early identification of stimulant treatment responders, partial responders and non-responders using objective measures in children and adolescents with hyperkinetic disorder.
Clinical gains from including both Dextroamphetamine and methylphenidate in stimulant trials.
Long-term functional outcome in adult prison inmates with ADHD receiving OROS-methylphenidate.
Objective QbTest and subjective evaluation of stimulant treatment in adult attention deficit-hyperactivity disorder.
Transcranial direct current stimulation improves clinical symptoms in adolescents with attention deficit hyperactivity disorder.
Effects of CBT on inattention, impulsivity and hyperactivity in children with behavior problems.